SCHEMBL20052352

SCHEMBL20052352

CCCC[C@H]1C(=O)N(C)[C@@H](CCCC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(N)=O)CSCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N(C)[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC)C(=O)N[C@@H](CC(C)C)C(=O)N2C[C@H](O)C[C@H]2C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC2(CC2)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N1C

nearest known ligand 0.67

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
CD274 Q9NZQ7 9/20 0.67
PDCD1 Q15116 7/20 0.64
CIB1 Q99828 4/20 0.56
ROR1 Q01973 1/20 0.46
KLKB1 P03952 3/20 0.46
EPHA2 P29317 1/20 0.43
PCSK9 Q8NBP7 1/20 0.43
F12 P00748 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17854752 0.98 CD274 (0.67) CD274PDCD1CIB1ROR1KLKB1
SCHEMBL20052340 0.97 CD274 (0.68) CD274PDCD1CIB1ROR1KLKB1
SCHEMBL17854770 0.97 CD274 (0.68) CD274PDCD1CIB1ROR1KLKB1
SCHEMBL20052313 0.96 CD274 (0.65) CD274PDCD1CIB1ROR1KLKB1
SCHEMBL20052316 0.96 CD274 (0.68) CD274PDCD1CIB1ROR1KLKB1
SCHEMBL20052335 0.95 CD274 (0.68) CD274PDCD1CIB1ROR1KLKB1
SCHEMBL17854772 0.95 CD274 (0.68) CD274PDCD1CIB1ROR1KLKB1
SCHEMBL20052309 0.95 CD274 (0.64) CD274PDCD1CIB1ROR1KLKB1
SCHEMBL20053745 0.95 CD274 (0.71) CD274PDCD1CIB1ROR1KLKB1
SCHEMBL17854747 0.94 CD274 (0.65) CD274PDCD1CIB1ROR1KLKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9944678-B2 Immunomodulators BRISTOL-MYERS SQUIBB COMPANY (US) 2018-04-17 US disclosed